Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-185783
Filing Date
2020-07-02
Accepted
2020-07-02 06:19:48
Documents
3
Group Members
ASPIRE CAPITAL PARTNERS, LLC 27-1406238CHRISKO INVESTORS, INC. 27-5414284CHRISTOS KOMISSOPOULOSERIK J. BROWNRED CEDAR CAPITAL CORP. 20-1313891SGM HOLDINGS CORP. 36-4303462STEVEN G. MARTINWILLIAM F. BLANK, IIIWML VENTURES CORP. 82-3709389

Document Format Files

Seq Description Document Type Size
1 SC 13G d926192dsc13g.htm SC 13G 191528
2 EX-99.1 d926192dex991.htm EX-99.1 13141
3 EX-99.2 d926192dex992.htm EX-99.2 8028
  Complete submission text file 0001193125-20-185783.txt   214557
Mailing Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606
Business Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606 312.658.0400
Aspire Capital Fund, LLC (Filed by) CIK: 0001535683 (see all company filings)

EIN.: 271406279
Type: SC 13G

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Subject) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91444 | Film No.: 201007114
SIC: 2834 Pharmaceutical Preparations